Important Notice on Abilify Compulsive Gambling Side Effects National Class Action

TAKE NOTICE that on December 12, 2019, the Honourable Justice Pierre-C. Gagnon of the Superior Court of Quebec authorized the bringing of a class action against Bristol-Myers Squibb Canada Co. and Otsuka Canada Pharmaceutical Inc. and appointed the status of representative plaintiff to Mr. Steven Scheer to act on behalf of the class of persons described above.

To read the notice and to join the class action, click on the following link:
https://www.clg.org/Class-Action/List-of-Class-Actions/Abilify-Compulsive-Gambling-Side-Effects-National-Class-Action